Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Appendectomy: a Randomized Controlled Trial
- Conditions
- Complications
- Interventions
- Procedure: suprapubic single-incision laparoscopic appendectomy
- Registration Number
- NCT02499016
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Brief Summary
Conventional laparoscopic appendectomy(CLA) is the current standard treatment. To obtain additional benefits such as a better cosmetic outcome, the investigators developed a surgical option termed suprapubic single-incision laparoscopic appendectomy (SSILA), which creates a non-visible scar, that was preliminarily shown to be feasible and safe in our previous retrospective studies To further evaluate the feasibility, safety and cosmetic results of this innovative approach, the investigators compared the outcomes of SSILA and CLA by performing a randomized controlled trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 208
- acute appendicitis or interval appendicitis
- informed consent
- diagnosis of appendicitis was not clinically established (symptoms attributable to urinary or gynecological problems)
- history of cirrhosis and coagulation disorders
- suspected or proven malignancy
- contraindication to general anesthesia (severe cardiac and/or pulmonary disease)
- inability to give informed consent(severe mental disease)
- pregnancy
- BMI>30kg/m2
- generalized peritonitis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description suprapubic single-incision laparoscopic appendectomy suprapubic single-incision laparoscopic appendectomy single incision laparoscopic surgery will be performed for patients in this group. conventional multiport appendectomy suprapubic single-incision laparoscopic appendectomy Conventional laparoscopic surgery will be performed for patients in this group.
- Primary Outcome Measures
Name Time Method incidence of complications 30 days The early morbidity rate is defined as the event observed during operation and within 30 days after surgery
- Secondary Outcome Measures
Name Time Method mortality rate 30 days operative time intraoperative time to recover 14 days Pain score 14 days Postoperative pain is recorded using the visual analog scale (VAS) pain score tool on postoperative day 1, 2, 3 and the day of discharge.
cosmetic results 30 days Cosmetic assessment is perform using body image scale and cosmetic scale.
Trial Locations
- Locations (1)
Nanfang Hospital, Southern Medical University
🇨🇳Guangzhou, Guangdong, China